VSee Health receives Nasdaq deficiency for late Q2 10-Q; delisting hearing Sept 9

VSEE HEALTH, INC.

Received additional Nasdaq deficiency notice on Aug 20, 2025 for failure to timely file Q2 2025 Form 10-Q.
Trading suspension stayed until Aug 28, 2025; Nasdaq Panel hearing scheduled Sept 9, 2025.
Company expects common stock (VSEE) and warrants (VSEEW) to trade on OTC Markets after suspension if no extension granted.
Prior deficiency (Aug 5, 2025) for late 2024 10-K and Q1 2025 10-Q; appeal already filed.
Company intends to file the late 10-Q as soon as practicable and address all filings at the Panel hearing.

item 3.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.